Trial Profile
Randomised Phase III Study Evaluating Adjuvant Chemotherapy After Resection of Stage III Colonic Adenocarcinoma in Patients of 70 and Over Intergroup Trial
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 22 Aug 2023
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary) ; Fluorouracil (Primary) ; Folinic acid (Primary) ; Oxaliplatin (Primary)
- Indications Adenocarcinoma; Colon cancer; Rectal cancer
- Focus Therapeutic Use
- Acronyms ADAGE; PRODIGE 34 ADAGE
- 16 Aug 2023 Planned primary completion date changed from 1 Aug 2023 to 1 Feb 2024.
- 01 Apr 2023 Results(n=491 ) published in the Digestive and Liver Disease
- 05 Jul 2017 New trial record